HMPS26: 4 Healthcare Marketing Trends Shaping Growth in 2026

Bypaulgruensfelder
Definitive Healthcare May 14, 2026
Read Full Article →
AI-Generated Summary

Healthcare marketing is at a genuine inflection point in 2026, with 68% of CMOs managing budget cuts while still accountable for growth, engagement, and patient loyalty. The 31st Healthcare Marketing & Physician Strategies Summit (HMPS26) surfaced four defining shifts: AI has moved from experimentation to active integration in predictive referral analytics, audience segmentation, and physician engagement workflows — with governance now front of mind; growth strategy and marketing teams are converging around shared data and enterprise accountability; consumer expectations shaped by retail and e-commerce are forcing providers to compete on experience rather than reputation or geography alone; and brand differentiation is increasingly critical as crowded markets make organizations sound alike. Source: Definitive Healthcare, a healthcare data and analytics company.

Why It Matters

For multi-site operators and PE-backed platforms, the convergence of marketing and growth strategy demands a new leadership posture — treating marketing as a revenue function, not a cost center. The brand differentiation challenge is especially acute for platforms managing multiple regional identities across acquired practices.

healthcare marketing strategyAI marketing adoptionconsumer experiencebrand differentiationphysician engagementCMO budget pressuremarketing-strategy convergence

While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.

Frequently asked questions

What percentage of healthcare CMOs are managing budget cuts while still being held accountable for growth in 2026?

68% of healthcare CMOs are navigating budget cuts in 2026 while remaining accountable for growth, patient engagement, and loyalty, according to findings presented at HMPS26. The squeeze is pushing many systems toward consolidated marketing and growth functions rather than siloed teams.

How is AI changing physician referral and audience segmentation strategies in healthcare marketing?

AI has moved from pilot projects to active integration in predictive referral analytics, audience segmentation, and physician engagement workflows, per HMPS26 findings. Marketing leaders are now prioritizing governance frameworks alongside adoption, reflecting growing scrutiny of how AI-driven targeting decisions get made.

Why are healthcare marketing and growth strategy teams converging into a single function?

Healthcare marketing and growth strategy teams are converging around shared data and enterprise-wide accountability for revenue outcomes, treating marketing as a revenue driver rather than a cost center. This shift is especially relevant for multi-site and PE-backed platforms managing fragmented regional brand identities across acquired practices.

Similar Posts

  • Four Forces Disrupting DSO Growth in 2026: PE, Integration, AI, and Diagnostics

    Bypaulgruensfelder

    Four major forces are reshaping DSO growth in 2026: private equity resurging in oral surgery (up 9.1% in PE deals), medical-dental integration expanding through health system partnerships, AI adoption at scale across patient communication and operations, and salivary diagnostics emerging as a clinical frontier. For DSO growth teams and PE investors, this signals where capital and clinical energy are concentrating — and what capabilities will separate market leaders from laggards through 2027.

  • The Attribution Problem Your Board Doesn’t Understand

    Bypaulgruensfelder

    Healthcare marketing attribution is genuinely hard for multi-site groups because patient journeys are long, largely offline, and privacy-constrained—and a budget you can’t defend is a budget that gets cut. Strategy Collective’s Matt Lee argues perfect attribution doesn’t exist, but ‘good enough’ attribution is achievable through four moves: call tracking, redesigned patient intake questions, a blended market-level report, and separating brand demand from generated demand. The bigger fix is reframing the board conversation itself. Instead of asking ‘is marketing working?’, leaders should ask ‘how do we make Market B look like Market A?’—shifting from an unwinnable ROI-proof debate to a comparative, market-level view that drives real reallocation decisions.

  • Q3 2026 AI Trends: What Growth Leaders Need to Track

    Bypaulgruensfelder

    The most useful AI question for growth-stage leaders in Q3 2026 has shifted from what models can do to what results they actually deliver. Summit Partners’ AI and data science team flags five developments to track: the conversation has moved from capability to production results; the binding constraint is rarely the model itself but data, workflow, and integration; agents are evolving from assistants to actors, with trust as the real limiting factor; the underlying economics of AI are being rewritten; and leaders must separate genuine signal from noise while recognizing what work stays human. The throughline is disciplined execution—turning promising pilots into dependable, measurable production systems.

  • PE’s Quieter Playbook: Joint Ventures With Nonprofit Health Systems

    Bypaulgruensfelder

    Private equity firms are increasingly expanding in healthcare through joint ventures with nonprofit health systems rather than outright buyouts, according to a new report from the Private Equity Stakeholder Project. The report finds 21.4% of private equity-owned hospitals are held through joint venture arrangements with nonprofit systems, and the structure now spans hospitals, inpatient rehab, hospice, home health, behavioral health, ambulatory surgery centers and urgent care — likely an undercount, since the tally covers only publicly identifiable arrangements. Case studies include ventures involving Lifepoint Health, Compassus, Ardent Health Services and Ascension. PESP argues these JVs have drawn far less scrutiny than traditional PE buyouts even as they become more common, prompting calls for greater oversight.

  • Why Penn Medicine Is Deploying AI Agents for Patient Intake

    Bypaulgruensfelder

    Penn Medicine is integrating K Health’s AI-powered patient intake agents into its virtual primary care service, testing whether an AI ‘team member’ in the patient-provider relationship improves outcomes. The agents collect symptoms and medical history before a visit and convert them into structured summaries that feed directly into the clinician’s existing workflow — providers start appointments already informed, and patients get routed to the right level of care. The same K Health technology already runs inside virtual care programs at Cedars-Sinai, Mayo Clinic, Mass General Brigham and Hartford HealthCare, with use cases ranging from new-patient acquisition to expanding primary care access. If the pilot succeeds, Penn plans to extend the agents into in-person primary care offices and specialty clinics.

  • Patient Portal Messages Have Surged 153% Since COVID, JAMA Study Finds

    Bypaulgruensfelder

    Patient-authored messages to providers have surged 153% since the COVID-19 pandemic, and a new JAMA study using Epic data finds the increase did not reduce telehealth or in-person visits. The authors conclude that patient messaging functions as an expansion of between-visit care rather than a substitute for it, and that the steady, gradual rise makes the trend likely to persist. Messaging was most common among female patients, patients aged 40 to 64, and those in affluent neighborhoods. The operational cost is significant: the AMA reports inbox overload is now a leading driver of physician burnout, with some physicians spending up to two hours nightly clearing their in-basket, and burnout conservatively costing health systems over $5 billion a year.